- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Mundipharma K.K.
Total 676 results
-
Janssen Pharmaceutical K.K.CompletedRespiratory Syncytial Virus InfectionsJapan
-
Janssen Pharmaceutical K.K.CompletedPain | Postoperative PainJapan
-
Janssen Pharmaceutical K.K.CompletedDermatitis, AtopicJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.TerminatedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedHepatitis C, ChronicJapan
-
Janssen Pharmaceutical K.K.CompletedPain | Diabetic Neuropathies | Neuralgia | Postherpetic NeuralgiaJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedSchizophreniaTaiwan, Japan, Korea, Republic of
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Taiwan Mundipharma Pharmaceuticals Ltd.Completed
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Pharmaceutical K.K.Active, not recruitingHematologic MalignanciesJapan
-
Janssen Pharmaceutical K.K.Completed
-
Hamamatsu Photonics K.K.Completed
-
Janssen Pharmaceutical K.K.Withdrawn
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Terminated
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.WithdrawnMacular Degeneration | Geographic Atrophy | Visual AcuityJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Solasia Pharma K.K.CompletedPeripheral T-cell LymphomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedHepatitis C, ChronicJapan
-
Janssen Pharmaceutical K.K.CompletedAttention-Deficit / Hyperactivity DisorderJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.CompletedMyelodysplastic SyndromeJapan
-
Janssen Pharmaceutical K.K.Completed